中国癌症杂志 ›› 2018, Vol. 28 ›› Issue (7): 532-537.doi: 10.19401/j.cnki.1007-3639.2018.07.010

• 论著 • 上一篇    下一篇

晚期癌症患者中医辨证分型分布及其同生存期的相关性分析研究

顾筱莉,成文武,陈萌蕾,刘明辉,张 哲,赵苇苇,张 晶   

  1. 复旦大学附属肿瘤医院综合治疗科,复旦大学上海医学院肿瘤系,上海 200032
  • 出版日期:2018-07-30 发布日期:2018-08-10
  • 通信作者: 成文武 E-mail: wenwucheng@yahoo.com
  • 基金资助:
    上海市科学技术委员会科研计划项目(15401933100)。

The characteristics of Traditional Chinese Medicine syndrome and its relationship with survival time among patients with advanced cancer

GU Xiaoli, CHENG Wenwu, CHEN Menglei, LIU Minghui, ZHANG Zhe, ZHAO Weiwei, ZHANG Jing   

  1. Department of Palliative Care, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2018-07-30 Online:2018-08-10
  • Contact: CHENG Wenwu E-mail: wenwucheng@yahoo.com

摘要: 背景与目的:晚期癌症患者的中医辨证分型具有同西医症状评估不同的特点。通过对晚期癌症患者进行中医辨证分型的分类,研究其同西医症状及患者生存期之间的相关性。方法:通过MD Anderson症状评估量表(MD Anderson Symptom Inventory-Chinese,MDASI-C)收集临床患者症状分布及强度,并通过望闻问切判断患者的中医辨证分型。描述性分析用于人口统计学及临床特征资料的分析。对辨证分型为肝肾阴虚型(Ⅳ型)和其他型的患者进行t检验及χ2检验。应用Kaplan-Meier方法计算生存期,Log-rank进行显著性检验。结果:根据中医辨证分型,227例晚期癌症患者中,Ⅳ型共82例(36%)。Ⅳ型与其他5型相比,乏力和气急的发生频率和强度均较高。Ⅳ型患者同其他5型患者之间生存差异有统计学意义(P<0.05)。美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)评分和Ⅳ型为晚期癌症患者生存期的预后因素。结论:本研究证实中医辨证分型对晚期癌症患者生存期有辨识作用,可提高晚期癌症生存期预测的准确性。在临床工作中,以此辅助检测病情变化,有助于临床医师更好地判断晚期癌症患者的生存预后。

关键词: 晚期癌症患者, 中医辨证分型, 症状评估, 生存质量, 生存期

Abstract: Background and purpose: Traditional Chinese Medicine (TCM) syndrome has different characteristics from symptom management of Western medicine. This study was focused on the characteristics of TCM syndrome in advanced cancer patients, and to study the correlation between TCM syndrome and Western medicine symptoms and their correlation with the survival time of patients. Methods: The symptom distribution and intensity of the patients were collected through MD Anderson Symptom Inventory-Chinese (MDASI-C). TCM syndrome was correlated by four ways of Chinese diagnosis (looking, listening, questioning and feeling the pulse). SPSS Statistical software package was used to analyze and process the data. Descriptive analysis was applied to the analysis of demographic and clinical characteristics. The t test and χ2 test were performed for patients with syndrome differentiation type Ⅳ and other groups. The survival time was calculated using Kaplan-Meier method, and log-rank test was performed to measure the difference. Results: According to TCM syndrome differentiation, 82 cases (36%) were diagnosed with liver and kidney Yin deficiency. Compared with the other 5 types, the frequency and intensity of fatigue and dyspnea were higher in patients with liver and kidney Yin deficiency. There was significant difference in survival time between type Ⅳ patients and other 5 type patients (P<0.05). Eastern Cooperative Oncology Group (ECOG) score and type Ⅳ TCM syndrome were the survival prognostic factors in advanced cancer patients. Conclusion: Through this study, we have enhanced the identification of TCM syndrome differentiation in the survival of patients with advanced cancer, and improved the accuracy of predicting the survival of patients with advanced cancer. In clinical work, TCM syndrome can be used to assist in the detection of disease changes. It may help clinicians to assess survival prognosis.

Key words: Advanced cancer patients, Traditional Chinese Medicine syndrome, Symptom management, Quality of life, Survival